Abstract

BackgroundInvasive candidiasis (IC) is a frequent and life-threatening infection in critically ill patients. The aim of this study was to evaluate the epidemiology of IC and the antifungal susceptibility of etiological agents in patients admitted to our surgical intensive care unit (SICU) in Spain.MethodsWe designed a prospective, observational, single center, population-based study in a SICU. We included all consecutive adult patients (≥18 years old) who had documented IC, either on admission or during their stay, between January 2012 and December 2013.ResultsThere were a total of 22 episodes of IC in the 1149 patients admitted during the 24-month study. The overall IC incidence was 19.1 cases per 1000 admissions. Thirteen cases of IC (59.1 %) were intra-abdominal candidiasis (IAC) and 9 (40.9 %) were candidemias. All cases of IAC were patients with secondary peritonitis and severe sepsis or septic shock. The overall crude mortality rate was 13.6 %; while, it was 33 % in patients with candidemia. All patients with IAC survived, including one patient with concomitant candidemia. The most common species causing IC was Candida albicans (13; 59.1 %) followed by Candida parapsilosis (5; 22.7 %), and Candida glabrata (2; 9.1 %). There was also one case each (4.5 %) of Candida krusei and Candida tropicalis. Thus, the ratio of non-C. albicans (9) to C. albicans (13) was 1:1.4. There was resistance to fluconazole and itraconazole in 13.6 % of cases. Resistance to other antifungals was uncommon.ConclusionsCandida parapsilosis was the second most common species after C. albicans, indicating the high prevalence of non-C. albicans species in the SICU. Resistance to azoles, particularly fluconazole, should be considered when starting an empirical treatment. Although IAC is a very frequent form of IC in critically ill surgical patients, prompt antifungal therapy and adequate source control appears to lead to a good outcome. However, our results are closely related to our ICU and any generalization must be taken with caution. Therefore, further investigations are needed.

Highlights

  • Invasive candidiasis (IC) is a frequent and life-threatening infection in critically ill patients

  • In 2 cases (9.1 %), IC was already present at ICU admission, while it occurred during the ICU stay in 20 cases (90.9 %), with a median onset time of 20 days (5–37.5)

  • We found that C. albicans was the leading agent (13 cases; 59.1 %), followed by C. parapsilosis (4 cases; 22.7 %) C. glabrata (2 cases; 9.1 %)

Read more

Summary

Introduction

Invasive candidiasis (IC) is a frequent and life-threatening infection in critically ill patients. The aim of this study was to evaluate the epidemiology of IC and the antifungal susceptibility of etiological agents in patients admitted to our surgical intensive care unit (SICU) in Spain. 15 % of health-care associated infections are caused by fungi and Candida accounts for 70–90 % of all invasive infections. Due to the poor outcome associated with IC in critically ill patients, an understanding of local epidemiologic trends and the antifungal susceptibility of etiological agents is crucial. The main goal of this study was to evaluate the epidemiology of IC in our surgical intensive care unit (SICU). We evaluated in vitro susceptibility of isolates and outcome of IC in our SICU during a 2-year period

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call